Logue Melissa, Savani Bipin N
Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center Nashville, TN, USA.
Am J Blood Res. 2013 May 5;3(2):102-6. Print 2013.
We are celebrating one millionth transplant in year 2013! With continued improvement in hematopoietic cell transplantation (HCT) outcome, the indications for HCT continue to grow. Furthermore the sources of stem cells and the number of suitable matches are expanding. At the same time, modified transplantation regimens have facilitated safer procedures despite increase in patient's age and comorbidies. In the current era, any patient indicated for HCT has a stem cell source and therefore steps to HCT and coordinated pre-transplant care is an integral part of management to improve transplant outcome. This review discusses our approach to the transplant evaluation process and this article will serve as a valuable tool for primary care physicians and referring hematologists/oncologists.
我们正在庆祝2013年第100万例移植手术!随着造血细胞移植(HCT)结果的持续改善,HCT的适应证不断增加。此外,干细胞来源和合适配型的数量也在不断扩大。与此同时,尽管患者年龄增长和合并症增多,但改良的移植方案使手术更加安全。在当今时代,任何适合HCT的患者都有干细胞来源,因此进行HCT的步骤以及协调的移植前护理是改善移植结果管理的一个组成部分。本综述讨论了我们对移植评估过程的方法,本文将成为初级保健医生和转诊血液科医生/肿瘤内科医生的宝贵工具。